{"DataElement":{"publicId":"6148980","version":"1","preferredName":"Target Lesions Response RECIST Overall Status","preferredDefinition":"Text to represent the overall response status calculation for target lesions at a particular time for patients who have measurable disease at baseline.","longName":"TGT_OVR_RESP_STAT","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"6148958","version":"1","preferredName":"Target Lesion Identification Response","preferredDefinition":"The identification of a lesion that is present at baseline, is measurable and is the primary target of the therapeutic intervention._Any act or phenomena, or behavior, constituting a reply or reaction of a living organism or its part to some foregoing stimulus or agent.","longName":"5889873v1.0:2193203v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"5889873","version":"1","preferredName":"Target Lesion Identification","preferredDefinition":"The identification of a lesion that is present at baseline, is measurable and is the primary target of the therapeutic intervention.","longName":"C94520","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Target Lesion Identification","conceptCode":"C94520","definition":"The identification of a lesion that is present at baseline, is measurable and is the primary target of the therapeutic intervention.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"52F6803F-39EF-4DFF-E053-F662850A35E5","latestVersionIndicator":"Yes","beginDate":"2017-06-27","endDate":null,"createdBy":"PATELV","dateCreated":"2017-06-27","modifiedBy":"ONEDATA","dateModified":"2017-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2193203","version":"1","preferredName":"Response","preferredDefinition":"Response is any act or phenomena, or behavior, constituting a reply or reaction of a living organism or its part to some foregoing stimulus or agent.","longName":"C25755","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Response","conceptCode":"C25755","definition":"Any act or phenomena, or behavior, constituting a reply or reaction of a living organism or its part to some foregoing stimulus or agent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"EACFDBFA-EFCE-25E6-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-12-09","endDate":null,"createdBy":"MAESKEB","dateCreated":"2004-12-09","modifiedBy":"DATA_LOADER","dateModified":"2005-10-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"RECISTv1.1:Response Evaluation Criteria in Solid Tumors v1.1","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"685306A0-0144-7944-E053-F662850A89D7","latestVersionIndicator":"Yes","beginDate":"2018-03-26","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-03-26","modifiedBy":"KNABLEJ","dateModified":"2018-03-26","changeDescription":"3/26/18 jk created per Rnd 5 community comments, focus group activities and 2017 iRECIST documentation.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6148937","version":"1","preferredName":"RECIST Target Lesions Overall Status","preferredDefinition":"Standard parameters to be used when documenting response of solid tumors to treatment; a set of published rules that define when cancer patients improve (\"respond\"), stay the same (\"stable\"), or worsen (\"progression\") during treatments. (from www.recist.com)_The identification of a lesion that is present at baseline, is measurable and is the primary target of the therapeutic intervention._Including everything._A condition or state at a particular time.","longName":"6148937v1.0","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"20","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Not all evaluated","valueDescription":"Not All Lesions Evaluated","ValueMeaning":{"publicId":"4273169","version":"1","preferredName":"Not All Lesions Evaluated","longName":"4273169","preferredDefinition":"Not all target lesions were assessed. Or not all non-target lesions were assessed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not All Lesions Evaluated","conceptCode":"C103424","definition":"Not all target lesions were assessed. Or not all non-target lesions were assessed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F72DFE87-DE58-5FDE-E040-BB89AD433D0A","latestVersionIndicator":"Yes","beginDate":"2014-04-16","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2014-04-16","modifiedBy":"COOPERM","dateModified":"2020-04-27","changeDescription":"Updated Long Name and Definition to match current NCIt. mc 4/27/2020","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6852E785-920B-794A-E053-F662850A39BB","beginDate":"2018-03-26","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-03-26","modifiedBy":"ONEDATA","dateModified":"2018-03-26","deletedIndicator":"No"},{"value":"CR","valueDescription":"Complete Remission","ValueMeaning":{"publicId":"3951936","version":"1","preferredName":"Complete Remission","longName":"3951936v1.00","preferredDefinition":"The disappearance of all signs of cancer in response to treatment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Complete Remission","conceptCode":"C4870","definition":"The disappearance of all signs of cancer in response to treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EB155E17-C5DA-CEC3-E040-BB89AD4342C2","latestVersionIndicator":"Yes","beginDate":"2013-11-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-11-13","modifiedBy":"SOKKERL","dateModified":"2023-04-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6852E785-9215-794A-E053-F662850A39BB","beginDate":"2017-08-30","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-03-26","modifiedBy":"ONEDATA","dateModified":"2018-03-26","deletedIndicator":"No"},{"value":"NE","valueDescription":"Unevaluable","ValueMeaning":{"publicId":"3153578","version":"1","preferredName":"Unevaluable","longName":"3153578","preferredDefinition":"Unable to be evaluated.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unevaluable","conceptCode":"C62222","definition":"Unable to be evaluated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"93AC689E-5DB2-5D7A-E040-BB89AD430948","latestVersionIndicator":"Yes","beginDate":"2010-10-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-10-28","modifiedBy":"KUMMEROA","dateModified":"2023-04-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6852E785-921F-794A-E053-F662850A39BB","beginDate":"2018-03-26","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-03-26","modifiedBy":"ONEDATA","dateModified":"2018-03-26","deletedIndicator":"No"},{"value":"Not done","valueDescription":"Not Done","ValueMeaning":{"publicId":"2568055","version":"1","preferredName":"Not Done","longName":"2568055","preferredDefinition":"Indicates a task, process or examination that has either not been initiated or not been completed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Done","conceptCode":"C49484","definition":"Indicates a task, process or examination that has either not been initiated or not been completed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D6E4-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-01-12","modifiedBy":"REEVESD","dateModified":"2014-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6852E785-9229-794A-E053-F662850A39BB","beginDate":"2018-03-26","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-03-26","modifiedBy":"ONEDATA","dateModified":"2018-03-26","deletedIndicator":"No"},{"value":"PD","valueDescription":"Progressive Disease","ValueMeaning":{"publicId":"3284666","version":"1","preferredName":"Progressive Disease","longName":"3284666v1.00","preferredDefinition":"A clinical, pathologic, and/or molecular finding indicating that the course of a disease is worsening in terms of extent or severity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Progressive Disease","conceptCode":"C35571","definition":"A clinical, pathologic, and/or molecular finding indicating that the course of a disease is worsening in terms of extent or severity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AD9FC7D6-531D-BE97-E040-BB89AD437875","latestVersionIndicator":"Yes","beginDate":"2011-09-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-09-23","modifiedBy":"MMADDINENI","dateModified":"2024-02-22","changeDescription":null,"administrativeNotes":"2023.5.17 Alt VM added per ticket request CADSR0002435. ak \r\n2023.3.15 Per LS at COG Protocol defined progressive disease (should have been added as a VM Alt Name for PV 3284666). ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6852E785-9233-794A-E053-F662850A39BB","beginDate":"2017-08-30","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-03-26","modifiedBy":"ONEDATA","dateModified":"2018-03-26","deletedIndicator":"No"},{"value":"PR","valueDescription":"Partial Remission","ValueMeaning":{"publicId":"3854969","version":"1","preferredName":"Partial Remission","longName":"3854969","preferredDefinition":"A finding indicating that there is a decrease in the size and the extent of tissue involvement by a malignant tumor in a patient.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Partial Remission","conceptCode":"C18058","definition":"A finding indicating that there is a decrease in the size and the extent of tissue involvement by a malignant tumor in a patient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E3DF4512-86B4-A83E-E040-BB89AD431C6D","latestVersionIndicator":"Yes","beginDate":"2013-08-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-08-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":"Manually curated for OHSU 10262.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6852E785-923D-794A-E053-F662850A39BB","beginDate":"2017-08-30","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-03-26","modifiedBy":"ONEDATA","dateModified":"2018-03-26","deletedIndicator":"No"},{"value":"SD","valueDescription":"Stable Disease","ValueMeaning":{"publicId":"3859302","version":"1","preferredName":"Stable Disease","longName":"3859302","preferredDefinition":"Cancer that is neither decreasing nor increasing in extent or severity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stable Disease","conceptCode":"C18213","definition":"A disease that is neither decreasing nor increasing in extent or severity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E461EC27-2518-B912-E040-BB89AD43049F","latestVersionIndicator":"Yes","beginDate":"2013-08-20","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2013-08-20","modifiedBy":"SOKKERL","dateModified":"2023-09-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6852E785-9247-794A-E053-F662850A39BB","beginDate":"2013-08-20","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-03-26","modifiedBy":"ONEDATA","dateModified":"2018-03-26","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6148959","version":"1","preferredName":"Response Evaluation Criteria in Solid Tumors Target Lesion Identification Overall Status","preferredDefinition":"Standard parameters to be used when documenting response of solid tumors to treatment; a set of published rules that define when cancer patients improve (\"respond\"), stay the same (\"stable\"), or worsen (\"progression\") during treatments. (from www.recist.com):The identification of a lesion that is present at baseline, is measurable and is the primary target of the therapeutic intervention.:Including everything.:A condition or state at a particular time.","longName":"C49164:C94520:C25605:C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Response Evaluation Criteria in Solid Tumors","conceptCode":"C49164","definition":"Standard parameters to be used when documenting response of solid tumors to treatment; a set of published rules that define when cancer patients improve (\"respond\"), stay the same (\"stable\"), or worsen (\"progression\") during treatments. (from www.recist.com)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Target Lesion Identification","conceptCode":"C94520","definition":"The identification of a lesion that is present at baseline, is measurable and is the primary target of the therapeutic intervention.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Overall","conceptCode":"C25605","definition":"Including everything.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"68536D04-7D0A-4EA4-E053-F662850AEB3E","latestVersionIndicator":"Yes","beginDate":"2018-03-26","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-03-26","modifiedBy":"ONEDATA","dateModified":"2018-03-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"RECISTv1.1:Response Evaluation Criteria in Solid Tumors v1.1","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"6852E785-91E9-794A-E053-F662850A39BB","latestVersionIndicator":"Yes","beginDate":"2018-03-26","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-03-26","modifiedBy":"COOPERM","dateModified":"2020-04-27","changeDescription":"3/26/18 jk VD created for overall summary response of all target lesions (Table 1) in RECISTv1.1 guidelines.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5635300","version":"1","longName":"Case Report Form (CRF) Modules","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"5635324","version":"1","longName":"RECIST","context":"NCI Standards"},{"publicId":"6006643","version":"1","longName":"RECISTv1.1","context":"NCI Standards"},{"publicId":"6006642","version":"1","longName":"irRECIST","context":"NCI Standards"}]}],"AlternateNames":[{"name":"6148958v1.0:6148937v1.0","type":"System-Generated","context":"NCI Standards"},{"name":"NCI Standards","type":"USED_BY","context":"NCI Standards"}],"ReferenceDocuments":[{"name":"Target lesions","type":"Preferred Question Text","description":"Target lesions","url":null,"context":"NCI Standards"},{"name":"EORTC-iRECIST-FU","type":"Alternate Question Text","description":"Response of target lesions","url":null,"context":"NCI Standards"},{"name":"iRECIST-2017","type":"REFERENCE","description":"iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics","url":null,"context":"NCI Standards"},{"name":"RECISTv1.1","type":"REFERENCE","description":"New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) dated 2009","url":null,"context":"NCI Standards"},{"name":"RECIST","type":"Alternate Question Text","description":"Target lesions","url":null,"context":"NCI Standards"},{"name":"irRECIST","type":"Alternate Question Text","description":"Target lesions","url":null,"context":"NCI Standards"},{"name":"RECIST instruction","type":"COMMENT","description":"Mandatory on Follow up form to capture the \"overall/all\" Target lesions response.  Note: Use CDE 3859354 to collect  individual target lesion response (log line).  This CDE maps to RECISTv1.1 guideline summary Table 1, \"Target Lesions\" column.","url":null,"context":"NCI Standards"}],"origin":"RECISTv1.1:Response Evaluation Criteria in Solid Tumors v1.1","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"6853D3D1-47B1-7D47-E053-F662850A0D42","latestVersionIndicator":"Yes","beginDate":"2018-03-26","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-03-26","modifiedBy":"KNABLEJ","dateModified":"2018-10-21","changeDescription":"3/26/18 jk created per Round 5 community comments, focus group activities and 2017 iRECIST documentation.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}